Read More Pharma Industry News AbbVie’s schizophrenia treatment crumbles, boosting Bristol Myers Squibb to the top Bristol Myers Squibb’s stock surged dramatically after pharmaceutical giant AbbVie announced disappointing results in its recent clinical trials… byPallavi MadhirajuNovember 11, 2024